Catastrophic Concomitant Arterial and Venous Thrombosis in a Mild COVID-19-Positive Patient

Abstract

Since its first discovery in late 2019, coronavirus disease 2019 (COVID-19) has been a global burden associated with significant morbidity and mortality. COVID-19 has been correlated with the development of hypercoagulable state that predisposes the patients to a higher risk of thromboembolism. Current evidence suggests higher incidence of thrombosis, particularly venous thrombosis, among hospitalized COVID-19 patients, mostly with critical illness. On the other hand, there is currently no data regarding the incidence of vivid thrombosis in ambulatory patients with mild COVID-19 and the incidence of concomitant arterial and venous thrombosis in COVID-19 is extremely rare. Herein, we describe catastrophic outcomes of concomitant lower limb arterial and venous thrombosis in a patient with mild COVID-19. This report highlights the occurrence of concomitant arterial and venous thrombosis in ambulatory setting and that this phenomenon resulted in catastrophic clinical consequences.

Keywords

acute limb ischemia - deep vein thrombosis - mild COVID-19 - ischemia-reperfusion injury - thrombectomy - ambulatory - anticoagulation

Authors' Contributions

R.A.N., N.T.N., M.I., and H.S.M. were involved in the management of the presented patient. N.T.N., M.I., H.S.M., and S.A. provided clinical expertise and data interpretation. R.A.N., N.T.N., M.I., H.S.M., and S.A. were involved in the literature search and review processes. R.A.N., N.T.N., M.I., H.S.M., and S.A. contributed in the conception and design of the manuscript. R.A.N. was in charge in writing the initial and revised version of the manuscript. N.T.N., M.I., H.S.M., and S.A. reviewed and approved the final manuscript.

Publikationsverlauf

Artikel online veröffentlicht:
01. Oktober 2021

• References

• 1 World Health Organization. COVID-19 Weekly Epidemiological Update 22. World Heal Organ [Internet]. 2021 ;(January):1–3. Accessed Aug 1, 2021 from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/weekly_epidemiological_update_22.pdf
• 2 Veerasuri S, Kulkarni SR, Wilson WR, Paravastu SCV. Bilateral acute lower limb ischemia secondary to COVID-19. Vasc Endovascular Surg 2021; 55 (02) 196-199
• 3 Topcu AC, Ariturk C, Yilmaz E. Acute limb ischemia in a COVID-19 patient. Thromb Updat 2021; 2 (November 2020): 100031
• 4 Bellosta R, Luzzani L, Natalini G. et al. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg 2020; 72 (06) 1864-1872
• 5 Schweblin C, Hachulla AL, Roffi M, Glauser F. Delayed manifestation of COVID-19 presenting as lower extremity multilevel arterial thrombosis: a case report. Eur Heart J Case Rep 2020; 4 (06) 1-4
• 6 Piazza G, Campia U, Hurwitz S. et al. Registry of arterial and venous thromboembolic complications in patients with COVID-19. J Am Coll Cardiol 2020; 76 (18) 2060-2072
• 7 Kaur P, Qaqa F, Ramahi A. et al. Acute upper limb ischemia in a patient with COVID-19. Hematol Oncol Stem Cell Ther 2020; S1658-3876 (20) 30096-0
• 8 Sehhat S, Talebzadeh H, Hakamifard A. et al. Acute mesenteric ischemia in a patient with COVID-19: a case report. Arch Iran Med 2020; 23 (09) 639-643
• 9 Castro-Verdes M, Gkouma A, Wort J. et al. Corona Virus Disease 2019 in situ arterial and venous thrombosis in critically ill patients: a case series. Eur Heart J Case Rep 2020; 4 (06) 1-7
• 10 Suhartono R, Nugroho NT. Dealing with hypercoagulability problem in COVID-19 Cases. J Indones Soc Vasc Endovasc Surg 2021; 2 (01) vi-vii
• 11 Overstad S, Tjonnfjord E, Garabet L. et al. Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - a report of 4 cases. Thromb Res 2020; 194: 116-118
• 12 Emert R, Shah P, Zampella JG. COVID-19 and hypercoagulability in the outpatient setting. Thromb Res 2020; 192: 122-123
• 13 Zhai Z, Li C, Chen Y. et al; Prevention Treatment of VTE Associated with COVID-19 Infection Consensus Statement Group. Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines. Thromb Haemost 2020; 120 (06) 937-948
• 14 Cuker A, Tseng EK, Nieuwlaat R. et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv 2021; 5 (03) 872-888
• 15 Demirci U, Ozdemir H, Demirbag-Kabayel D, Umit EG, Demir AM. Reducing the risk of venous thrombosis during self-isolation and covid-19 pandemic for patients with cancer: focus on home exercises prescription. Clin Appl Thromb Hemost 2020; 26: 1076029620933947
• 16 de Barry O, Mekki A, Diffre C, Seror M, El Hajjam M, Carlier RY. Arterial and venous abdominal thrombosis in a 79-year-old woman with COVID-19 pneumonia. Radiol Case Rep 2020; 15 (07) 1054-1057
• 17 Kichloo A, Dettloff K, Aljadah M. et al. COVID-19 and hypercoagulability: a review. Clin Appl Thromb Hemost 2020; 26: 1076029620962853
• 18 Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020; 135 (23) 2033-2040
• 19 Wright FL, Vogler TO, Moore EE. et al. Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection. J Am Coll Surg 2020; 231 (02) 193-203.e1
• 20 Dorweiler B, Pruefer D, Andrasi TB. et al. Ischemia-reperfusion injury. Eur J Trauma Emerg Surg 2007; 33 (06) 600-612